Ask AI

Conference to Clinic: Advances in the Management of NPM1-Mutant and KMT2A-Rearranged AML

Improve your understanding of current and emerging menin inhibitors for the treatment of NPM1-mutant and KMT2A-rearranged AML to inform treatment strategies through downloadable slides.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Kura Oncology, Inc.

Kura Oncology, Inc.